These publications were authored or co-authored by Quest Diagnostics staff.
Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma.Authors: Li Y, Bare LA, Bender RA, Sninsky JJ, Wilson LS, Devlin JJ, Waldman FM
Mol Diagn Ther. 2015;19:169-77
The Measurement of 3-Epimer 25-Hydroxyvitamin D by Mass Spectrometry in Clinical Specimens Detects Inconsequential Levels in Adult SubjectsQuest Diagnostics Authors: Caulfield, MP, Clarke, NJ, McPhaul, MJ, Reitz, R
Authors: Goldman, Mildred M. BS, CLS; Viec, Khanh V. BS;
Journal of Investigative Medicine
J Thromb Haemost. 2012;10:1320-1325.
Eosinophilic cytoplasmic inclusion bodies in vesicular multinucleated melanocytes: a clue to the diagnosis of benign melanocytic lesions.Authors: Patino WD, Hutchens KA, Kapil J, Chiou Y, Gottlieb GJ.
Am J Dermatopathol. 2012;34:424-427.
False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.Authors: Sahud M, Zhukov O, Mo K, Popov J, Dlott J.
Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy.Authors: Shiffman D, Trompet S, Louie JZ, Rowland CM, Catanese JJ, Iakoubova OA, Kirchgessner TG, Westendorp RG, de Craen AJ, Slagboom PE, Buckley BM, Stott DJ, Sattar N, Devlin JJ, Packard CJ, Ford I, Sacks FM, Jukema JW.
PLoS One. 2012;7:e38240.